December 5, 2017
RegMed Investors’ (RMi) pre-open indication: buy the oversold, sell the overbought and dump the “Ponzi’s”
December 4, 2017
RegMed Investors’ (RMi) pre-open indication: the blindside
December 1, 2017
RegMed Investors’ (RMi) pre-open indication: new month starts with an ominous IBB -88.89% indication
November 30, 2017
RegMed Investors’ (RMi) pre-open indication: who is today's audience?
November 29, 2017
RegMed Investors’ (RMi) pre-open indication: news is aphorismatic
November 28, 2017
RegMed Investors’ (RMi) pre-open indication: the sector was down in a count
November 27, 2017
RegMed Investors’ (RMi) pre-open indications; cyber Monday
November 24, 2017
RegMed Investors’ (RMi) pre-open indications; thin trading expected again
November 22, 2017
RegMed Investors’ (RMi) pre-open indications; no turkey yet
November 21, 2017
RegMed Investors’ (RMi) pre-open indications; the current sector resistance
November 20, 2017
RegMed Investors’ (RMi) pre-open indications; holiday and end of the month getting closer
November 17, 2017
RegMed Investors’ (RMi) pre-open indications; what to watch for …
November 16, 2017
RegMed Investors’ (RMi) pre-open indications; covering the bases
November 15, 2017
RegMed Investors’ (RMi) pre-open indications; flack vest or a checkbook?
November 14, 2017
RegMed Investors’ (RMi) pre-open indications; have you been read in …
November 13, 2017
RegMed Investors’ (RMi) pre-open indications; we are stuck in a trading pit versus an investing suite
November 10, 2017
RegMed Investors’ (RMi) pre-open indications; it’s time for a break …
November 9, 2017
RegMed Investors’ (RMi) pre-open indications; is there a pricing at which a share value’s sustainable
November 8, 2017
RegMed Investors’ (RMi) pre-open indications; a dead week
November 7, 2017
RegMed Investors’ (RMi) pre-open indications; companies’ loyalty to investors has just slipped away
November 6, 2017
RegMed Investors’ (RMi) pre-open indications; be prepared to navigate Q3 reporting
November 3, 2017
RegMed Investors’ (RMi) pre-open indications; never be too long …
November 2, 2017
RegMed Investors’ (RMi) pre-open indications; give me a reason for …
November 1, 2017
RegMed Investors’ (RMi) pre-open indications; Q3 quarterly results set the tone
October 31, 2017
RegMed Investors’ (RMi) pre-open indications; get ready for reporting season
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.